Enveric BiosciencesENVB
13F holders, Q2 2025 (June 30)14holders −1
4new positions
5sold out
1famous investor
$1.21avg. 13F price*
At the end of Q2 2025, 14 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, down 1 from Q1 2025. 4 opened new positions and 5 sold out. The largest holders were AdvisorShares Investments LLC ($125K), Renaissance Technologies ($45K) and Geode Capital Management, LLC ($34K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $61K |
| Exits | 5 | $89K |
All 13F filers, Q1 2025 → Q2 2025: 65,599 shares bought and 84,680 shares sold, net −19,081 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| AdvisorShares Investments LLC | 0.02% | Add +14.8% | 103,679 | $125K |
| Renaissance Technologies | 0.00% | New | 37,012 | $45K |
| Geode Capital Management, LLC | 0.00% | Add +6.0% | 28,160 | $34K |
| UBS Group AG | 0.00% | Reduce -36.1% | 27,339 | $33K |
| Virtu Financial LLC | 0.00% | Reduce -19.0% | 20,757 | $25K |
| Morgan Stanley | 0.00% | New | 13,020 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +24.7% | 2,957 | $4K |
| BlackRock, Inc. | 0.00% | No change | 601 | $727 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -17.2% | 600 | $726 |
| Bank of America Corp. | 0.00% | New | 24 | $29 |
| National Bank of Canada | 0.00% | No change | 5 | $6 |
| Wells Fargo & Company | 0.00% | No change | 2 | $2 |
| Jones Financial Companies LLLP | 0.00% | New | 1 | $1 |
| Group One Trading LLC | 0.00% | Reduce -94.7% | 1 | $1 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.